The frailty index is a predictor of cause-specific mortality independent of familial effects from midlife onwards: a large cohort study
Background Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects influence the associations. Middle-aged individuals are also understudied for the association between FI and mortality. Furthermore, the p...
Gespeichert in:
| Veröffentlicht in: | BMC medicine Jg. 17; H. 1; S. 94 - 10 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
London
BioMed Central
15.05.2019
BioMed Central Ltd Springer Nature B.V BMC |
| Schlagworte: | |
| ISSN: | 1741-7015, 1741-7015 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Background
Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects influence the associations. Middle-aged individuals are also understudied for the association between FI and mortality. Furthermore, the population mortality impact of frailty remains understudied.
Methods
We estimated the predictive value of FI for all-cause and cause-specific mortality, taking into account familial factors, and tested whether the associations are time-dependent. We also assessed the proportion of all-cause and cause-specific deaths that are attributable to increased levels of frailty. We analyzed 42,953 participants from the Screening Across the Lifespan Twin Study (aged 41–95 years at baseline) with up to 20 years’ mortality follow-up. The FI was constructed using 44 health-related items. Deaths due to cardiovascular disease (CVD), respiratory-related causes, and cancer were considered in the cause-specific analysis. Generalized survival models were used in the analysis.
Results
Increased FI was associated with higher risks of all-cause, CVD, and respiratory-related mortality, with the corresponding hazard ratios of 1.28 (1.24, 1.32), 1.31 (1.23, 1.40), and 1.23 (1.11, 1.38) associated with a 10% increase in FI in male single responders, and 1.21 (1.18, 1.25), 1.27 (1.15, 1.34), and 1.26 (1.15, 1.39) in female single responders. No significant associations were observed for cancer mortality. No attenuation of the mortality associations in unrelated individuals was observed when adjusting for familial effects in twin pairs. The associations were time-dependent with relatively greater effects observed in younger ages. Before the age of 80, the proportions of deaths attributable to FI levels > 0.21 were 18.4% of all-cause deaths, 25.4% of CVD deaths, and 20.4% of respiratory-related deaths in men and 19.2% of all-cause deaths, 27.8% of CVD deaths, and 28.5% of respiratory-related deaths in women. After the age of 80, the attributable proportions decreased, most notably for all-cause and CVD mortality.
Conclusions
Increased FI predicts higher risks of all-cause, CVD, and respiratory-related mortality independent of familial effects. Increased FI presents a relatively greater risk factor at midlife than in old age. Increased FI has a significant population mortality impact that is greatest through midlife until the age of 80. |
|---|---|
| AbstractList | Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects influence the associations. Middle-aged individuals are also understudied for the association between FI and mortality. Furthermore, the population mortality impact of frailty remains understudied. We estimated the predictive value of FI for all-cause and cause-specific mortality, taking into account familial factors, and tested whether the associations are time-dependent. We also assessed the proportion of all-cause and cause-specific deaths that are attributable to increased levels of frailty. We analyzed 42,953 participants from the Screening Across the Lifespan Twin Study (aged 41-95 years at baseline) with up to 20 years' mortality follow-up. The FI was constructed using 44 health-related items. Deaths due to cardiovascular disease (CVD), respiratory-related causes, and cancer were considered in the cause-specific analysis. Generalized survival models were used in the analysis. Increased FI was associated with higher risks of all-cause, CVD, and respiratory-related mortality, with the corresponding hazard ratios of 1.28 (1.24, 1.32), 1.31 (1.23, 1.40), and 1.23 (1.11, 1.38) associated with a 10% increase in FI in male single responders, and 1.21 (1.18, 1.25), 1.27 (1.15, 1.34), and 1.26 (1.15, 1.39) in female single responders. No significant associations were observed for cancer mortality. No attenuation of the mortality associations in unrelated individuals was observed when adjusting for familial effects in twin pairs. The associations were time-dependent with relatively greater effects observed in younger ages. Before the age of 80, the proportions of deaths attributable to FI levels > 0.21 were 18.4% of all-cause deaths, 25.4% of CVD deaths, and 20.4% of respiratory-related deaths in men and 19.2% of all-cause deaths, 27.8% of CVD deaths, and 28.5% of respiratory-related deaths in women. After the age of 80, the attributable proportions decreased, most notably for all-cause and CVD mortality. Increased FI predicts higher risks of all-cause, CVD, and respiratory-related mortality independent of familial effects. Increased FI presents a relatively greater risk factor at midlife than in old age. Increased FI has a significant population mortality impact that is greatest through midlife until the age of 80. Background Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects influence the associations. Middle-aged individuals are also understudied for the association between FI and mortality. Furthermore, the population mortality impact of frailty remains understudied. Methods We estimated the predictive value of FI for all-cause and cause-specific mortality, taking into account familial factors, and tested whether the associations are time-dependent. We also assessed the proportion of all-cause and cause-specific deaths that are attributable to increased levels of frailty. We analyzed 42,953 participants from the Screening Across the Lifespan Twin Study (aged 41–95 years at baseline) with up to 20 years’ mortality follow-up. The FI was constructed using 44 health-related items. Deaths due to cardiovascular disease (CVD), respiratory-related causes, and cancer were considered in the cause-specific analysis. Generalized survival models were used in the analysis. Results Increased FI was associated with higher risks of all-cause, CVD, and respiratory-related mortality, with the corresponding hazard ratios of 1.28 (1.24, 1.32), 1.31 (1.23, 1.40), and 1.23 (1.11, 1.38) associated with a 10% increase in FI in male single responders, and 1.21 (1.18, 1.25), 1.27 (1.15, 1.34), and 1.26 (1.15, 1.39) in female single responders. No significant associations were observed for cancer mortality. No attenuation of the mortality associations in unrelated individuals was observed when adjusting for familial effects in twin pairs. The associations were time-dependent with relatively greater effects observed in younger ages. Before the age of 80, the proportions of deaths attributable to FI levels > 0.21 were 18.4% of all-cause deaths, 25.4% of CVD deaths, and 20.4% of respiratory-related deaths in men and 19.2% of all-cause deaths, 27.8% of CVD deaths, and 28.5% of respiratory-related deaths in women. After the age of 80, the attributable proportions decreased, most notably for all-cause and CVD mortality. Conclusions Increased FI predicts higher risks of all-cause, CVD, and respiratory-related mortality independent of familial effects. Increased FI presents a relatively greater risk factor at midlife than in old age. Increased FI has a significant population mortality impact that is greatest through midlife until the age of 80. Background Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects influence the associations. Middle-aged individuals are also understudied for the association between FI and mortality. Furthermore, the population mortality impact of frailty remains understudied. Methods We estimated the predictive value of FI for all-cause and cause-specific mortality, taking into account familial factors, and tested whether the associations are time-dependent. We also assessed the proportion of all-cause and cause-specific deaths that are attributable to increased levels of frailty. We analyzed 42,953 participants from the Screening Across the Lifespan Twin Study (aged 41–95 years at baseline) with up to 20 years’ mortality follow-up. The FI was constructed using 44 health-related items. Deaths due to cardiovascular disease (CVD), respiratory-related causes, and cancer were considered in the cause-specific analysis. Generalized survival models were used in the analysis. Results Increased FI was associated with higher risks of all-cause, CVD, and respiratory-related mortality, with the corresponding hazard ratios of 1.28 (1.24, 1.32), 1.31 (1.23, 1.40), and 1.23 (1.11, 1.38) associated with a 10% increase in FI in male single responders, and 1.21 (1.18, 1.25), 1.27 (1.15, 1.34), and 1.26 (1.15, 1.39) in female single responders. No significant associations were observed for cancer mortality. No attenuation of the mortality associations in unrelated individuals was observed when adjusting for familial effects in twin pairs. The associations were time-dependent with relatively greater effects observed in younger ages. Before the age of 80, the proportions of deaths attributable to FI levels > 0.21 were 18.4% of all-cause deaths, 25.4% of CVD deaths, and 20.4% of respiratory-related deaths in men and 19.2% of all-cause deaths, 27.8% of CVD deaths, and 28.5% of respiratory-related deaths in women. After the age of 80, the attributable proportions decreased, most notably for all-cause and CVD mortality. Conclusions Increased FI predicts higher risks of all-cause, CVD, and respiratory-related mortality independent of familial effects. Increased FI presents a relatively greater risk factor at midlife than in old age. Increased FI has a significant population mortality impact that is greatest through midlife until the age of 80. Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects influence the associations. Middle-aged individuals are also understudied for the association between FI and mortality. Furthermore, the population mortality impact of frailty remains understudied. We estimated the predictive value of FI for all-cause and cause-specific mortality, taking into account familial factors, and tested whether the associations are time-dependent. We also assessed the proportion of all-cause and cause-specific deaths that are attributable to increased levels of frailty. We analyzed 42,953 participants from the Screening Across the Lifespan Twin Study (aged 41-95 years at baseline) with up to 20 years' mortality follow-up. The FI was constructed using 44 health-related items. Deaths due to cardiovascular disease (CVD), respiratory-related causes, and cancer were considered in the cause-specific analysis. Generalized survival models were used in the analysis. Increased FI was associated with higher risks of all-cause, CVD, and respiratory-related mortality, with the corresponding hazard ratios of 1.28 (1.24, 1.32), 1.31 (1.23, 1.40), and 1.23 (1.11, 1.38) associated with a 10% increase in FI in male single responders, and 1.21 (1.18, 1.25), 1.27 (1.15, 1.34), and 1.26 (1.15, 1.39) in female single responders. No significant associations were observed for cancer mortality. No attenuation of the mortality associations in unrelated individuals was observed when adjusting for familial effects in twin pairs. The associations were time-dependent with relatively greater effects observed in younger ages. Before the age of 80, the proportions of deaths attributable to FI levels > 0.21 were 18.4% of all-cause deaths, 25.4% of CVD deaths, and 20.4% of respiratory-related deaths in men and 19.2% of all-cause deaths, 27.8% of CVD deaths, and 28.5% of respiratory-related deaths in women. After the age of 80, the attributable proportions decreased, most notably for all-cause and CVD mortality. Increased FI predicts higher risks of all-cause, CVD, and respiratory-related mortality independent of familial effects. Increased FI presents a relatively greater risk factor at midlife than in old age. Increased FI has a significant population mortality impact that is greatest through midlife until the age of 80. BACKGROUND: Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects influence the associations. Middle-aged individuals are also understudied for the association between FI and mortality. Furthermore, the population mortality impact of frailty remains understudied. METHODS: We estimated the predictive value of FI for all-cause and cause-specific mortality, taking into account familial factors, and tested whether the associations are time-dependent. We also assessed the proportion of all-cause and cause-specific deaths that are attributable to increased levels of frailty. We analyzed 42,953 participants from the Screening Across the Lifespan Twin Study (aged 41-95 years at baseline) with up to 20 years' mortality follow-up. The FI was constructed using 44 health-related items. Deaths due to cardiovascular disease (CVD), respiratory-related causes, and cancer were considered in the cause-specific analysis. Generalized survival models were used in the analysis. RESULTS: Increased FI was associated with higher risks of all-cause, CVD, and respiratory-related mortality, with the corresponding hazard ratios of 1.28 (1.24, 1.32), 1.31 (1.23, 1.40), and 1.23 (1.11, 1.38) associated with a 10% increase in FI in male single responders, and 1.21 (1.18, 1.25), 1.27 (1.15, 1.34), and 1.26 (1.15, 1.39) in female single responders. No significant associations were observed for cancer mortality. No attenuation of the mortality associations in unrelated individuals was observed when adjusting for familial effects in twin pairs. The associations were time-dependent with relatively greater effects observed in younger ages. Before the age of 80, the proportions of deaths attributable to FI levels > 0.21 were 18.4% of all-cause deaths, 25.4% of CVD deaths, and 20.4% of respiratory-related deaths in men and 19.2% of all-cause deaths, 27.8% of CVD deaths, and 28.5% of respiratory-related deaths in women. After the age of 80, the attributable proportions decreased, most notably for all-cause and CVD mortality. CONCLUSIONS: Increased FI predicts higher risks of all-cause, CVD, and respiratory-related mortality independent of familial effects. Increased FI presents a relatively greater risk factor at midlife than in old age. Increased FI has a significant population mortality impact that is greatest through midlife until the age of 80. Abstract Background Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects influence the associations. Middle-aged individuals are also understudied for the association between FI and mortality. Furthermore, the population mortality impact of frailty remains understudied. Methods We estimated the predictive value of FI for all-cause and cause-specific mortality, taking into account familial factors, and tested whether the associations are time-dependent. We also assessed the proportion of all-cause and cause-specific deaths that are attributable to increased levels of frailty. We analyzed 42,953 participants from the Screening Across the Lifespan Twin Study (aged 41–95 years at baseline) with up to 20 years’ mortality follow-up. The FI was constructed using 44 health-related items. Deaths due to cardiovascular disease (CVD), respiratory-related causes, and cancer were considered in the cause-specific analysis. Generalized survival models were used in the analysis. Results Increased FI was associated with higher risks of all-cause, CVD, and respiratory-related mortality, with the corresponding hazard ratios of 1.28 (1.24, 1.32), 1.31 (1.23, 1.40), and 1.23 (1.11, 1.38) associated with a 10% increase in FI in male single responders, and 1.21 (1.18, 1.25), 1.27 (1.15, 1.34), and 1.26 (1.15, 1.39) in female single responders. No significant associations were observed for cancer mortality. No attenuation of the mortality associations in unrelated individuals was observed when adjusting for familial effects in twin pairs. The associations were time-dependent with relatively greater effects observed in younger ages. Before the age of 80, the proportions of deaths attributable to FI levels > 0.21 were 18.4% of all-cause deaths, 25.4% of CVD deaths, and 20.4% of respiratory-related deaths in men and 19.2% of all-cause deaths, 27.8% of CVD deaths, and 28.5% of respiratory-related deaths in women. After the age of 80, the attributable proportions decreased, most notably for all-cause and CVD mortality. Conclusions Increased FI predicts higher risks of all-cause, CVD, and respiratory-related mortality independent of familial effects. Increased FI presents a relatively greater risk factor at midlife than in old age. Increased FI has a significant population mortality impact that is greatest through midlife until the age of 80. Background Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects influence the associations. Middle-aged individuals are also understudied for the association between FI and mortality. Furthermore, the population mortality impact of frailty remains understudied. Methods We estimated the predictive value of FI for all-cause and cause-specific mortality, taking into account familial factors, and tested whether the associations are time-dependent. We also assessed the proportion of all-cause and cause-specific deaths that are attributable to increased levels of frailty. We analyzed 42,953 participants from the Screening Across the Lifespan Twin Study (aged 41-95 years at baseline) with up to 20 years' mortality follow-up. The FI was constructed using 44 health-related items. Deaths due to cardiovascular disease (CVD), respiratory-related causes, and cancer were considered in the cause-specific analysis. Generalized survival models were used in the analysis. Results Increased FI was associated with higher risks of all-cause, CVD, and respiratory-related mortality, with the corresponding hazard ratios of 1.28 (1.24, 1.32), 1.31 (1.23, 1.40), and 1.23 (1.11, 1.38) associated with a 10% increase in FI in male single responders, and 1.21 (1.18, 1.25), 1.27 (1.15, 1.34), and 1.26 (1.15, 1.39) in female single responders. No significant associations were observed for cancer mortality. No attenuation of the mortality associations in unrelated individuals was observed when adjusting for familial effects in twin pairs. The associations were time-dependent with relatively greater effects observed in younger ages. Before the age of 80, the proportions of deaths attributable to FI levels > 0.21 were 18.4% of all-cause deaths, 25.4% of CVD deaths, and 20.4% of respiratory-related deaths in men and 19.2% of all-cause deaths, 27.8% of CVD deaths, and 28.5% of respiratory-related deaths in women. After the age of 80, the attributable proportions decreased, most notably for all-cause and CVD mortality. Conclusions Increased FI predicts higher risks of all-cause, CVD, and respiratory-related mortality independent of familial effects. Increased FI presents a relatively greater risk factor at midlife than in old age. Increased FI has a significant population mortality impact that is greatest through midlife until the age of 80. Keywords: Frailty index, Mortality, Familial effect, Time-varying effect, Attributable fraction Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects influence the associations. Middle-aged individuals are also understudied for the association between FI and mortality. Furthermore, the population mortality impact of frailty remains understudied.BACKGROUNDFrailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects influence the associations. Middle-aged individuals are also understudied for the association between FI and mortality. Furthermore, the population mortality impact of frailty remains understudied.We estimated the predictive value of FI for all-cause and cause-specific mortality, taking into account familial factors, and tested whether the associations are time-dependent. We also assessed the proportion of all-cause and cause-specific deaths that are attributable to increased levels of frailty. We analyzed 42,953 participants from the Screening Across the Lifespan Twin Study (aged 41-95 years at baseline) with up to 20 years' mortality follow-up. The FI was constructed using 44 health-related items. Deaths due to cardiovascular disease (CVD), respiratory-related causes, and cancer were considered in the cause-specific analysis. Generalized survival models were used in the analysis.METHODSWe estimated the predictive value of FI for all-cause and cause-specific mortality, taking into account familial factors, and tested whether the associations are time-dependent. We also assessed the proportion of all-cause and cause-specific deaths that are attributable to increased levels of frailty. We analyzed 42,953 participants from the Screening Across the Lifespan Twin Study (aged 41-95 years at baseline) with up to 20 years' mortality follow-up. The FI was constructed using 44 health-related items. Deaths due to cardiovascular disease (CVD), respiratory-related causes, and cancer were considered in the cause-specific analysis. Generalized survival models were used in the analysis.Increased FI was associated with higher risks of all-cause, CVD, and respiratory-related mortality, with the corresponding hazard ratios of 1.28 (1.24, 1.32), 1.31 (1.23, 1.40), and 1.23 (1.11, 1.38) associated with a 10% increase in FI in male single responders, and 1.21 (1.18, 1.25), 1.27 (1.15, 1.34), and 1.26 (1.15, 1.39) in female single responders. No significant associations were observed for cancer mortality. No attenuation of the mortality associations in unrelated individuals was observed when adjusting for familial effects in twin pairs. The associations were time-dependent with relatively greater effects observed in younger ages. Before the age of 80, the proportions of deaths attributable to FI levels > 0.21 were 18.4% of all-cause deaths, 25.4% of CVD deaths, and 20.4% of respiratory-related deaths in men and 19.2% of all-cause deaths, 27.8% of CVD deaths, and 28.5% of respiratory-related deaths in women. After the age of 80, the attributable proportions decreased, most notably for all-cause and CVD mortality.RESULTSIncreased FI was associated with higher risks of all-cause, CVD, and respiratory-related mortality, with the corresponding hazard ratios of 1.28 (1.24, 1.32), 1.31 (1.23, 1.40), and 1.23 (1.11, 1.38) associated with a 10% increase in FI in male single responders, and 1.21 (1.18, 1.25), 1.27 (1.15, 1.34), and 1.26 (1.15, 1.39) in female single responders. No significant associations were observed for cancer mortality. No attenuation of the mortality associations in unrelated individuals was observed when adjusting for familial effects in twin pairs. The associations were time-dependent with relatively greater effects observed in younger ages. Before the age of 80, the proportions of deaths attributable to FI levels > 0.21 were 18.4% of all-cause deaths, 25.4% of CVD deaths, and 20.4% of respiratory-related deaths in men and 19.2% of all-cause deaths, 27.8% of CVD deaths, and 28.5% of respiratory-related deaths in women. After the age of 80, the attributable proportions decreased, most notably for all-cause and CVD mortality.Increased FI predicts higher risks of all-cause, CVD, and respiratory-related mortality independent of familial effects. Increased FI presents a relatively greater risk factor at midlife than in old age. Increased FI has a significant population mortality impact that is greatest through midlife until the age of 80.CONCLUSIONSIncreased FI predicts higher risks of all-cause, CVD, and respiratory-related mortality independent of familial effects. Increased FI presents a relatively greater risk factor at midlife than in old age. Increased FI has a significant population mortality impact that is greatest through midlife until the age of 80. |
| ArticleNumber | 94 |
| Audience | Academic |
| Author | Pedersen, Nancy L. Ploner, Alexander Hägg, Sara Li, Xia Karlsson, Ida K. Liu, Xingrong Jylhävä, Juulia Magnusson, Patrik K. E. |
| Author_xml | – sequence: 1 givenname: Xia surname: Li fullname: Li, Xia organization: The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet – sequence: 2 givenname: Alexander surname: Ploner fullname: Ploner, Alexander organization: The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet – sequence: 3 givenname: Ida K. surname: Karlsson fullname: Karlsson, Ida K. organization: The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Institute of Gerontology and Aging Research Network – Jönköping (ARN-J), School of Health and Welfare, Jönköping University – sequence: 4 givenname: Xingrong surname: Liu fullname: Liu, Xingrong organization: The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet – sequence: 5 givenname: Patrik K. E. surname: Magnusson fullname: Magnusson, Patrik K. E. organization: The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet – sequence: 6 givenname: Nancy L. surname: Pedersen fullname: Pedersen, Nancy L. organization: The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet – sequence: 7 givenname: Sara surname: Hägg fullname: Hägg, Sara organization: The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet – sequence: 8 givenname: Juulia orcidid: 0000-0003-0250-4491 surname: Jylhävä fullname: Jylhävä, Juulia email: juulia.jylhava@ki.se organization: The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31088449$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-43973$$DView record from Swedish Publication Index (Högskolan i Jönköping) http://kipublications.ki.se/Default.aspx?queryparsed=id:140929920$$DView record from Swedish Publication Index (Karolinska Institutet) |
| BookMark | eNp9k1trFDEYhgep2IP-AG8kIIggU3OaScYLodRToeBN9TZkctjNmpmsScbaX-DfNtPd2m5RGWYSvnneN_Dm-w6rvTGMpqqeIniMEG9fJ4Q71NYQdTUiBNX8QXWAGEU1g6jZu7Pfrw5TWkGIG8boo2qfIMg5pd1B9etiaYCN0vl8BdyozU_gEpBgHY12KocIggVKTsnUaW2Us06BIcQsvdsK1qZ8xjxzVg7OO-mBsdaonIpxGMDgtHfWgDBeyqjTm-LuZVwYoMKyOIGUJ331uHpopU_myXY9qr58eH9x-qk-__zx7PTkvFYM8lxbaCGTHCLMuGwwbzGTslE9VYb0SlOrEdEE6bZTlLK25xgqKC3GVElmICJH1dnGVwe5EuvoBhmvRJBOXBdCXAgZs1PeCAabvu8sURw1lFHSG8ZbqYnCuie0vEdVvfFKl2Y99Ttu29K3sjOCso4jXPhX_-Tfua8n16cvV4KSjpFCv93QBR2MViXjKP2OaPfP6JZiEX6ItkGcIVgMXm4NYvg-mZTF4JIy3svRhCkJjAmGmHPSFfT5PXQVpjiWiygUZpC2iMJbaiFLPG60oZyrZlNx0vC2gbxp5oSP_0KVR5vBqdLA1pX6juDFHcHSSJ-XKfgpuzCmXfDZ3UT-RHHTzQVgG0DFkFI0ViiX5eyT5w4XCIp5bsRmbkSZGzHPjeBFie4pb8z_p8Hb6yzsuDDxNrR_i34DgagqLA |
| CitedBy_id | crossref_primary_10_1097_PSY_0000000000000742 crossref_primary_10_1093_ageing_afab106 crossref_primary_10_1186_s12877_023_04633_3 crossref_primary_10_1186_s12916_021_02104_3 crossref_primary_10_1007_s10522_019_09818_1 crossref_primary_10_1111_jgs_17089 crossref_primary_10_1093_pubmed_fdaa226 crossref_primary_10_1097_CNQ_0000000000000428 crossref_primary_10_1111_ggi_15066 crossref_primary_10_1016_j_archger_2021_104598 crossref_primary_10_1097_CNQ_0000000000000565 crossref_primary_10_1016_j_jacasi_2025_04_013 crossref_primary_10_1016_S2468_2667_20_30113_4 crossref_primary_10_1111_acel_13459 crossref_primary_10_3233_JAD_215475 crossref_primary_10_1016_j_jamda_2021_08_030 crossref_primary_10_1093_ageing_afaf075 crossref_primary_10_1016_j_maturitas_2020_05_010 crossref_primary_10_1016_j_jamda_2022_10_005 crossref_primary_10_1111_ggi_14738 crossref_primary_10_1007_s12603_023_2037_3 crossref_primary_10_1016_j_scitotenv_2022_159829 crossref_primary_10_1186_s12877_022_03404_w crossref_primary_10_1016_j_jbmt_2023_06_008 crossref_primary_10_1093_ageing_afae028 crossref_primary_10_1136_jech_2023_221761 crossref_primary_10_1161_HYPERTENSIONAHA_124_24214 crossref_primary_10_1007_s40264_023_01390_5 crossref_primary_10_1007_s00068_022_02145_0 crossref_primary_10_1136_bmjopen_2020_047051 crossref_primary_10_1177_17474930231194676 crossref_primary_10_1016_j_clnu_2020_10_044 crossref_primary_10_1186_s12933_020_01103_7 crossref_primary_10_1159_000534131 crossref_primary_10_1186_s12916_020_01870_w crossref_primary_10_18632_aging_206307 crossref_primary_10_1038_s43587_021_00099_3 crossref_primary_10_1371_journal_pone_0258588 crossref_primary_10_1007_s11357_023_00783_9 crossref_primary_10_1016_j_exger_2021_111475 crossref_primary_10_7554_eLife_51507 crossref_primary_10_1093_ageing_afaa056 crossref_primary_10_1007_s11606_024_09335_z crossref_primary_10_1016_j_archger_2022_104906 |
| Cites_doi | 10.1093/biomet/asq023 10.1007/s10549-017-4222-8 10.1016/j.cger.2010.08.008 10.1186/s12916-015-0400-x 10.1093/annonc/mdu540 10.1007/BF03324754 10.1186/1471-2318-9-47 10.1111/jgs.15220 10.1101/233692 10.1186/s12877-016-0329-8 10.1177/0962280216664760 10.1177/0962280217727558 10.1016/S0140-6736(12)62167-9 10.18632/aging.101352 10.1089/rej.2016.1905 10.1186/1471-2318-11-17 10.1093/gerona/56.3.M146 10.1002/sim.7451 10.1093/ageing/afx162 10.1002/sim.5767 10.1016/j.arr.2012.03.001 10.1093/biostatistics/kxr038 10.1016/j.exger.2016.12.021 10.1186/s13195-014-0054-5 10.1007/s10654-014-9891-6 10.1017/thg.2016.72 10.1017/thg.2012.104 10.1111/jgs.13821 10.1186/1471-2318-8-24 10.1093/biostatistics/kxj023 10.1177/0962280214564003 10.1093/gerona/63.10.1053 10.1503/cmaj.101271 10.1093/aje/kwy128 10.1186/s12877-016-0317-z 10.1016/j.jamda.2013.03.022 |
| ContentType | Journal Article |
| Copyright | The Author(s). 2019 COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s). 2019 – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM AABRY ADTPV AOWAS D8T D8X ZZAVC DOA |
| DOI | 10.1186/s12916-019-1331-8 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Databases ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Högskolan i Jönköping full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Högskolan i Jönköping SwePub Articles full text DOAJ : Directory of Open Access Journals [open access] |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Full Text url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1741-7015 |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_705bb9f3c8154743be786ad3c2db34db oai_swepub_ki_se_479812 oai_DiVA_org_hj_43973 PMC6518710 A586508551 31088449 10_1186_s12916_019_1331_8 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: the Loo & Hans Osterman Foundation – fundername: the Strategic Research Program in Epidemiology at Karolinska Institutet – fundername: China Scholarship Council funderid: http://dx.doi.org/10.13039/501100004543 – fundername: National Institutes of Health grantid: AG08724 funderid: http://dx.doi.org/10.13039/100000002 – fundername: the Foundation for Geriatric Diseases – fundername: Vetenskapsrådet grantid: 2017-00641, 2015-03255, 2018-02077 funderid: http://dx.doi.org/10.13039/501100004359 – fundername: the Magnus Bergwall Foundation – fundername: NIA NIH HHS grantid: R01 AG008724 – fundername: ; – fundername: ; grantid: 2017-00641, 2015-03255, 2018-02077 – fundername: ; grantid: AG08724 |
| GroupedDBID | --- 0R~ 23N 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB AAYXX AFFHD CITATION -5E -5G -A0 -BR 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7QL 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PKEHL PQEST PQUKI 7X8 5PM 2VQ AABRY ADTPV AHSBF AOWAS C1A D8T D8X H13 IPNFZ RIG ZZAVC |
| ID | FETCH-LOGICAL-c708t-f0f07a801278a528627aa5cb4ce3bcd4fd13d31d69c4476b820c0af224ca7e013 |
| IEDL.DBID | PIMPY |
| ISICitedReferencesCount | 58 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000468058000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1741-7015 |
| IngestDate | Fri Oct 03 12:28:34 EDT 2025 Tue Nov 25 03:32:54 EST 2025 Tue Nov 04 15:57:49 EST 2025 Tue Nov 04 01:56:11 EST 2025 Thu Oct 02 11:41:18 EDT 2025 Wed Oct 08 14:20:58 EDT 2025 Tue Nov 11 10:05:10 EST 2025 Tue Nov 04 17:43:27 EST 2025 Thu May 22 21:09:10 EDT 2025 Thu Jan 02 22:59:23 EST 2025 Sat Nov 29 04:08:17 EST 2025 Tue Nov 18 21:53:42 EST 2025 Sat Sep 06 07:29:18 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Attributable fraction Frailty index Time-varying effect Mortality Familial effect |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c708t-f0f07a801278a528627aa5cb4ce3bcd4fd13d31d69c4476b820c0af224ca7e013 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-0250-4491 |
| OpenAccessLink | https://www.proquest.com/publiccontent/docview/2227046140?pq-origsite=%requestingapplication% |
| PMID | 31088449 |
| PQID | 2227046140 |
| PQPubID | 42775 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_705bb9f3c8154743be786ad3c2db34db swepub_primary_oai_swepub_ki_se_479812 swepub_primary_oai_DiVA_org_hj_43973 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6518710 proquest_miscellaneous_2232028839 proquest_journals_2227046140 gale_infotracmisc_A586508551 gale_infotracacademiconefile_A586508551 gale_healthsolutions_A586508551 pubmed_primary_31088449 crossref_citationtrail_10_1186_s12916_019_1331_8 crossref_primary_10_1186_s12916_019_1331_8 springer_journals_10_1186_s12916_019_1331_8 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-05-15 |
| PublicationDateYYYYMMDD | 2019-05-15 |
| PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC medicine |
| PublicationTitleAbbrev | BMC Med |
| PublicationTitleAlternate | BMC Med |
| PublicationYear | 2019 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | A Sjölander (1331_CR11) 2017; 26 C Handforth (1331_CR36) 2015; 26 T Shamliyan (1331_CR22) 2013; 12 JS Mandelblatt (1331_CR35) 2017; 164 L Chen (1331_CR19) 2010; 97 K Rockwood (1331_CR5) 2011; 27 A Sjölander (1331_CR17) 2013; 32 RS Crow (1331_CR33) 2018; 66 JE Morley (1331_CR37) 2013; 14 X Song (1331_CR30) 2014; 6 AC Young (1331_CR7) 2016; 19 LP Fried (1331_CR3) 2001; 56 DM Williams (1331_CR25) 2017 1331_CR28 M Clements (1331_CR21) 2018 A Oksuzyan (1331_CR27) 2008; 20 A Clegg (1331_CR1) 2013; 381 PK Magnusson (1331_CR13) 2013; 16 Gotaro Kojima (1331_CR6) 2017; 47 M Jiang (1331_CR23) 2017; 9 HS Lin (1331_CR2) 2016; 16 Elisabeth Dahlqwist (1331_CR16) 2017; 28 M Taguri (1331_CR12) 2012; 13 SD Searle (1331_CR4) 2008; 8 J Shi (1331_CR31) 2011; 11 XR Liu (1331_CR15) 2017; 36 EH Gordon (1331_CR8) 2017; 89 A Mitnitski (1331_CR9) 2015; 13 KU Saum (1331_CR24) 2014; 29 MM Bartley (1331_CR29) 2016; 64 N Veronese (1331_CR34) 2017; 20 Xing-Rong Liu (1331_CR14) 2016; 27 K Rockwood (1331_CR20) 2011; 183 YQ Chen (1331_CR10) 2006; 7 1331_CR18 AM Kulminski (1331_CR26) 2008; 63 JJ García-González (1331_CR32) 2009; 9 |
| References_xml | – volume: 97 start-page: 713 issue: 3 year: 2010 ident: 1331_CR19 publication-title: Biometrika doi: 10.1093/biomet/asq023 – volume: 164 start-page: 107 issue: 1 year: 2017 ident: 1331_CR35 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-017-4222-8 – volume-title: rstpm2: generalized survival models. R package version 1.4.1 year: 2018 ident: 1331_CR21 – volume: 27 start-page: 17 issue: 1 year: 2011 ident: 1331_CR5 publication-title: Clin Geriatr Med doi: 10.1016/j.cger.2010.08.008 – volume: 13 start-page: 161 year: 2015 ident: 1331_CR9 publication-title: BMC Med doi: 10.1186/s12916-015-0400-x – volume: 26 start-page: 1091 issue: 6 year: 2015 ident: 1331_CR36 publication-title: Ann Oncol doi: 10.1093/annonc/mdu540 – volume: 20 start-page: 91 issue: 2 year: 2008 ident: 1331_CR27 publication-title: Aging Clin Exp Res doi: 10.1007/BF03324754 – volume: 9 start-page: 47 year: 2009 ident: 1331_CR32 publication-title: BMC Geriatr doi: 10.1186/1471-2318-9-47 – volume: 66 start-page: 496 issue: 3 year: 2018 ident: 1331_CR33 publication-title: J Am Geriatr Soc doi: 10.1111/jgs.15220 – volume-title: A frailty index for UK Biobank participants year: 2017 ident: 1331_CR25 doi: 10.1101/233692 – volume: 16 start-page: 157 issue: 1 year: 2016 ident: 1331_CR2 publication-title: BMC Geriatr doi: 10.1186/s12877-016-0329-8 – volume: 27 start-page: 1531 issue: 5 year: 2016 ident: 1331_CR14 publication-title: Statistical Methods in Medical Research doi: 10.1177/0962280216664760 – volume: 28 start-page: 462 issue: 2 year: 2017 ident: 1331_CR16 publication-title: Statistical Methods in Medical Research doi: 10.1177/0962280217727558 – volume: 381 start-page: 752 issue: 9868 year: 2013 ident: 1331_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(12)62167-9 – volume: 9 start-page: 2629 issue: 12 year: 2017 ident: 1331_CR23 publication-title: Aging (Albany NY) doi: 10.18632/aging.101352 – volume: 20 start-page: 517 issue: 6 year: 2017 ident: 1331_CR34 publication-title: Rejuvenation Res doi: 10.1089/rej.2016.1905 – volume: 11 start-page: 17 year: 2011 ident: 1331_CR31 publication-title: BMC Geriatr doi: 10.1186/1471-2318-11-17 – volume: 56 start-page: M146 issue: 3 year: 2001 ident: 1331_CR3 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/56.3.M146 – volume: 36 start-page: 4743 issue: 29 year: 2017 ident: 1331_CR15 publication-title: Stat Med doi: 10.1002/sim.7451 – volume: 47 start-page: 193 issue: 2 year: 2017 ident: 1331_CR6 publication-title: Age and Ageing doi: 10.1093/ageing/afx162 – volume: 32 start-page: 3067 issue: 18 year: 2013 ident: 1331_CR17 publication-title: Stat Med doi: 10.1002/sim.5767 – volume: 12 start-page: 719 issue: 2 year: 2013 ident: 1331_CR22 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2012.03.001 – volume: 13 start-page: 455 issue: 3 year: 2012 ident: 1331_CR12 publication-title: Biostatistics doi: 10.1093/biostatistics/kxr038 – volume: 89 start-page: 30 year: 2017 ident: 1331_CR8 publication-title: Exp Gerontol doi: 10.1016/j.exger.2016.12.021 – volume: 6 start-page: 54 issue: 5–8 year: 2014 ident: 1331_CR30 publication-title: Alzheimers Res Ther doi: 10.1186/s13195-014-0054-5 – volume: 29 start-page: 171 issue: 3 year: 2014 ident: 1331_CR24 publication-title: Eur J Epidemiol doi: 10.1007/s10654-014-9891-6 – volume: 19 start-page: 600 issue: 6 year: 2016 ident: 1331_CR7 publication-title: Twin Res Hum Genet doi: 10.1017/thg.2016.72 – volume: 16 start-page: 317 issue: 1 year: 2013 ident: 1331_CR13 publication-title: Twin Res Hum Genet doi: 10.1017/thg.2012.104 – volume: 64 start-page: 132 issue: 1 year: 2016 ident: 1331_CR29 publication-title: J Am Geriatr Soc doi: 10.1111/jgs.13821 – volume: 8 start-page: 24 year: 2008 ident: 1331_CR4 publication-title: BMC Geriatr doi: 10.1186/1471-2318-8-24 – volume: 7 start-page: 515 issue: 4 year: 2006 ident: 1331_CR10 publication-title: Biostatistics doi: 10.1093/biostatistics/kxj023 – volume: 26 start-page: 948 issue: 2 year: 2017 ident: 1331_CR11 publication-title: Stat Methods Med Res doi: 10.1177/0962280214564003 – volume: 63 start-page: 1053 issue: 10 year: 2008 ident: 1331_CR26 publication-title: J Gerontol A Biol doi: 10.1093/gerona/63.10.1053 – volume: 183 start-page: E487 issue: 8 year: 2011 ident: 1331_CR20 publication-title: CMAJ doi: 10.1503/cmaj.101271 – ident: 1331_CR18 doi: 10.1093/aje/kwy128 – ident: 1331_CR28 doi: 10.1186/s12877-016-0317-z – volume: 14 start-page: 392 issue: 6 year: 2013 ident: 1331_CR37 publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2013.03.022 |
| SSID | ssj0025774 |
| Score | 2.4801686 |
| Snippet | Background
Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial... Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial effects... Background Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial... BACKGROUND: Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether familial... Abstract Background Frailty index (FI) is a well-established predictor of all-cause mortality, but less is known for cause-specific mortality and whether... |
| SourceID | doaj swepub pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 94 |
| SubjectTerms | Adult Age Aged Aged, 80 and over Aging - physiology Attenuation Attributable fraction Biomedicine Cancer Cardiovascular diseases Cardiovascular Diseases - mortality Cause of Death Cohort analysis Cohort Studies Familial effect Family Health - statistics & numerical data Fatalities Female Follow-Up Studies Frailty Frailty - diagnosis Frailty - etiology Frailty - mortality Frailty index Gender differences Health aspects Health risk assessment Health Status Indicators Humans Life span Male Medicine Medicine & Public Health Men Middle Aged Middle aged persons Mortality Older people Patient outcomes Prognosis Research Article Respiratory tract diseases Risk analysis Risk Factors Time dependence Time-varying effect Twins |
| SummonAdditionalLinks | – databaseName: DOAJ : Directory of Open Access Journals [open access] dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQhRAXxJtAASNVIIGiOokTO9yWR8UBKg5Q9WbZjqOmbLNVkq3UX8DfZsbxhqagcuG2iiebxDOZ-SYef0PIjpNGMsNlzHQGCQoA_thwU8ZVaiAfycpKeuL5g89if18eHpZfL7T6wpqwkR54nLhdwXJjyjqzEoI9hDvjhCx0ldm0MhmvDHpfQD2bZCqkWjmgmrCGmchit4eolmDmXMaQkyWxnEUhT9b_p0u-EJMu10tOi6aXCEZ9UNq7TW4FNEkX41PcIddce5fc-BLWy--Rn2AFtO50sxzOqSdGpE1PNT3tUATSbbqqqdXr3sW45RLLhuiJB-RNOGFskTugnP8WAuZKQw0Ixa0p9KSplk3t6KrF-tv-Lfz7EqvLKbbe7Qbq-Wvvk-97H7-9_xSH1guxFUwOcc1qJjRGLyF1nkLaI7TOreHWZcZWvK6SrMqSqigt56IAvTLLdA14wGrhAFY-IFvtqnWPCE0RowCuLCEKgrcoNOTydSplbbHBhE0jwjaqUDbwkmN7jKXy-Yks1Kg9BdpTqD0lI_J6OuV0JOW4Svgd6ncSRD5tfwCsTAUrU_-ysog8R-tQ4-bUySuoRS4R4gLsjMgrL4F-AW7f6rC9ASYBGbZmktszSXif7Xx4Y4Eq-JNe4Y5lpMbnLCIvpmE8E2vkWrdao0yWMmweXUbk4Wiw00MDiJeScxgRM1Oezcp8pG2OPNt4kSeQVMN132yM_vdtXTHpO-N7MbvAh-Zg4af96FghEM4i8vIvYuHQD_jlFBclYNDH_0OJT8jNFF0Acu_m22Rr6NbuKbluz4am7555B_ILpCZ0Dg priority: 102 providerName: Directory of Open Access Journals – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELagIMQL9xEoYKQKJFCEN3Fih7flqHiACnGs-mbZjkMD22yVZJH4BfxtZhxvIKWqBG-reLx2Zuf4Zj0zJmTHSSOZ4TJmOoUABQB_bLgp4jIxEI-kRSl94_nFW7G3J_f3i_ehjrvbZLtvjiS9pfZqLfNnHXimGUa_RQxx1SyWZ8k58HYStfHDx8UYZWUAaMLx5YnTJg7I9-n_2xr_4Y6Op0qO56XHeot6f7R7-b_e5Aq5FOAnnQ_ycpWccc01cuFdOGC_Tn6C2NCq1fWy_0F9J0Vad1TToxZJID6nq4pave5cjDWamGdEDz2Cr8OE4U7dHun8nycg3zQkjVCsZaGHdbmsK0dXDSbsds_h25eYjk7xrt62p77h7Q3yeff1p5dv4nBXQ2wFk31csYoJje5OSJ0lECcJrTNruHWpsSWvyllaprMyLyznIgdBYJbpCgCE1cIBDr1JtppV424TmiCoASBagNsE85JrCP6rRMrK4o0UNokI2_yAyoZG5nifxlL5gEbmamCwAgYrZLCSEXkyTjkaunicRvwCpWIkxAbc_sGq_aKCPivBMmOKKrUSMChs2DgBOy1Tm5Qm5aWJyAOUKTVUs45mRM0ziZgYcGpEHnsKNCSwfatDPQQwAVtyTSi3J5RgAOx0eCO3KhigTmGJM_bS5ywiD8dhnIlJdY1brZEmTRjeNl1E5NYg5uNLA-qXknMYERMFmHBlOtLUB749eZ7NIAqHdZ9upP_3tk5h-s6gTZMFXtWLuWf7wVeFyDmNyKMTyMKjb_DJKS7AJiR3_mn1u-RiguqIXXmzbbLVt2t3j5y33_u6a-97-_IL5S13NA priority: 102 providerName: Springer Nature |
| Title | The frailty index is a predictor of cause-specific mortality independent of familial effects from midlife onwards: a large cohort study |
| URI | https://link.springer.com/article/10.1186/s12916-019-1331-8 https://www.ncbi.nlm.nih.gov/pubmed/31088449 https://www.proquest.com/docview/2227046140 https://www.proquest.com/docview/2232028839 https://pubmed.ncbi.nlm.nih.gov/PMC6518710 https://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-43973 http://kipublications.ki.se/Default.aspx?queryparsed=id:140929920 https://doaj.org/article/705bb9f3c8154743be786ad3c2db34db |
| Volume | 17 |
| WOSCitedRecordID | wos000468058000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: RBZ dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Open Access Full Text customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: DOA dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: M~E dateStart: 20030101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: RSV dateStart: 20031201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdYixAvfH8ERjHSBBIoaj5rhxfUwSaQWFUNmMqTFTsJC3RJSVIk_gL-be4cNyMD9YmXqo3PieOez7-zz78jZC_lkjsy4LYT--CgAOC3ZSAjO_Ek-CN-lHBNPH_yns1mfLGI5uZ4dG3CKjc2URvqlu0Z47bBCI-TUuGK-RhPcCJVeOC8Wn23MYcU7rWahBo7ZIjEW3xAhvN3R_PPnQMWAtYxO5sun4xrmOtc9KcjGzw11-a9uUlT-P9tqP-YqS5GUXZbqRdoR_VUdXj9_77kDXLNQFY6bXXsJrmUFrfIlSOzKX-b_AJVo1kV58vmJ9XsizSvaUxXFYqAT0_LjKp4Xac2nuvE2CR6plF_biq0eXgblNMLLjAmqAk0oXj-hZ7lyTLPUloWGORbv4S7LzGEnWJ-36qhmiT3Dvl0ePDx9Vvb5HewFXN4Y2dO5rAYp0jG49AD34rFcahkoFJfqiTIEtdPfDeZRCoI2ASUx1FOnAHoUDFLAbveJYOiLNL7hHoIhAC8RjDVgkmaxKn0Mo_zTGEWC-VZxNn8s0IZ8nPMwbEU2gniE9EqgwBlEKgMglvkeVdl1TJ_bBPeR3XpBJG0W18oqy_C2ADBnFDKKPMVB9wKDZYpg5YmvvIS6QeJtMhjVDbRnoDtTI-YhhxxNGBbizzTEmh8oPkqNmcooBOQxqsnuduTBKOh-sUbBRTGaNXiXN8s8qQrxpoYiFek5RplfM_BDNWRRe61-t-9NHgKnAcBlLDeyOj1Sr-kyE81pfkkdMFzh-e-2Iyh82Zt6fS9dpj1HvAmP5nqbj_9KhBt-xZ5-g8xc-kbfEtFwCIAug-2d8pDctVDW4HUveEuGTTVOn1ELqsfTV5XI7LDFkx_8hEZ7h_M5scjvcAzMlYIfh1_OPkN5rST9A |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VgoAL74eh0EUqIIGs-r1rJIQCpWrVtOJQqtwW73pNDakdbAfUX8C_4Tcys3YSXFBuPXCLvGNnM5n5ZsY7D0I2NJfckQG3ncSHAAUcflsGMrZTT0I84scpN43nj4bs4ICPRvGHFfJrVguDaZUzTDRAnZYK35FvYs0mNgcPnDeTbzZOjcLT1dkIjVYs9vTpDwjZ6te7W_D_PvW87feH73bsbqqArZjDGztzMoclCMyMJ6EHHj1LklDJQGlfqjTIUtdPfTeNYhUELIItO8pJMjB1KmEaPCZ47gVyEXCcYQoZGy0CvBB8qe7k1OXRZg221MV4PbYhEnRt3rN9ZkTA34bgD0t4NktzflR7pq2pMYXb1_83Jt4g1zqnmw5aLblJVnRxi1ze79IKbpOfoCw0q5J83JxS0z-S5jVN6KRCkqasaJlRlUxrbWNlKmZX0RMTt-TdDe0k4QbpzCsj0GrapcpQrOChJ3k6zjNNywLTlOtX8PQxJuFTnFBcNdS0-b1DPp4LG-6S1aIs9H1CPXTlwP2OwVkAUI0SLb3M4zxTOIdDeRZxZrIjVNe-HaeIjIUJ43gkWnETIG4CxU1wi7yY3zJpe5csI36LAjknxLbj5kJZfRYdignmhFLGma84eN6wYakZ7DT1lZdKP0ilRdZRnEVbwzsHTzEIOUYC4J1b5LmhQPiE7aukqwIBJmAjsh7lWo8SYE_1l2ciLjrYrcVCvi3yZL6Md2IqYaHLKdL4noMztmOL3Gs1bP6jIdbhPAhghfV0r8eV_kqRH5um7FHocvDWLfJypqWLbS1h-karyL0v2MqPBobtx18Exgu-RZ79g6y79BU-aRGwGFz1B8uZsk6u7BzuD8Vw92DvIbnqITJhI-Jwjaw21VQ_IpfU9yavq8cG1yj5dN4Y8BsdVd5P |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1tb9MwELZgoIkvvL8EBjPSBBJTtDRxEodvhVGBGNUkoNo3y3Yclq1LqyRF4hfwt7lz3EDGNAnxrYrPtXM9n5-rz88RsmO44oFi3A9kBAEKAH5fMZX5eaggHomynFvi-dlBOp3yo6Ps0NU5bdbZ7usjye5OA7I0Ve3eMi-6Jc6TvQZ2qRFGwpkPMdbI51fJNYY1gzBc_zzrI64YwI07yryw22Azspz9f3vmP7am82mT_dnpOZ5RuzdNbv33W90mNx0spePOju6QK6a6SzY_uYP3e-QnmBMtalnO2x_UMizSsqGSLmsUgbidLgqq5aoxPt7dxPwjemaRfek6dLV2W5Szf6qA3VOXTELxjgs9K_N5WRi6qDCRt3kN3z7HNHWKNXzrlloi3Pvk6-Tdl7fvfVfDwddpwFu_CIoglbgNplzGIcRPqZSxVkybSOmcFfkoyqNRnmSasTQBAwl0IAsAFlqmBvDpA7JRLSrziNAQwQ4A1Ay2U3A7iTQqLELOC42VKnTokWD9YwrtCM6xzsZc2ECHJ6JTsAAFC1Sw4B551XdZduwelwm_QQvpBZGY2z5Y1N-EW-ciDWKlsiLSHLApTFiZFGaaRzrMVcRy5ZFttC_R3XLt3YsYxxyxMuBXj7y0EuhgYPpaunsSoASk6hpIbg0kwTHoYfPahoVzTI3Aq8_Isc8Cjzzvm7EnJttVZrFCmSgMsAp15pGHncn3Lw3RAOeMQUs6WAwDrQxbqvLY0pYn8Qiicxh3d70Sfk_rEqXvdCtrMMB-ORtbtR-fCETUkUdeXCDmHp3CJyNYmgGYffxPo2-TzcP9iTj4MP34hNwIcWUicW-8RTbaemWekuv6e1s29TPrdn4BgpWC_A |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+frailty+index+is+a+predictor+of+cause-specific+mortality+independent+of+familial+effects+from+midlife+onwards%3A+a+large+cohort+study&rft.jtitle=BMC+medicine&rft.au=Li%2C+Xia&rft.au=Ploner%2C+Alexander&rft.au=Karlsson%2C+Ida+K&rft.au=Liu%2C+Xingrong&rft.date=2019-05-15&rft.pub=Springer+Nature+B.V&rft.eissn=1741-7015&rft.volume=17&rft_id=info:doi/10.1186%2Fs12916-019-1331-8 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1741-7015&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1741-7015&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1741-7015&client=summon |